Indeed, the low-grade systemic inflammation in children with MetS and T2DM, characterized by the augmented levels of tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), interleukin- (IL-) 1, and IL-6, has been previously described [7]. This evidence concerns the gene IFNG and type 2 diabetes mellitus.